The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 25, 2017
Filed:
Apr. 01, 2016
Applicant:
Gilead Sciences, Inc., Foster City, CA (US);
Inventors:
Zhenhong R. Cai, Palo Alto, CA (US);
Haolun Jin, Foster City, CA (US);
Scott E. Lazerwith, San Francisco, CA (US);
Hyung-Jung Pyun, Fremont, CA (US);
Assignee:
GILEAD SCIENCES, INC., Foster City, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 513/22 (2006.01); A61K 31/4985 (2006.01); A61K 31/5365 (2006.01); A61K 45/06 (2006.01); C07D 491/22 (2006.01); C07D 498/16 (2006.01); C07D 498/22 (2006.01); A61K 31/4375 (2006.01); C07D 491/14 (2006.01); C07D 498/14 (2006.01);
U.S. Cl.
CPC ...
C07D 513/22 (2013.01); A61K 31/4375 (2013.01); A61K 31/4985 (2013.01); A61K 31/5365 (2013.01); A61K 45/06 (2013.01); C07D 491/14 (2013.01); C07D 491/22 (2013.01); C07D 498/14 (2013.01); C07D 498/16 (2013.01); C07D 498/22 (2013.01);
Abstract
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (Ia): including stereoisomers and pharmaceutically acceptable salts thereof, wherein A, A', Rand Rare as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.